USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 16, 2022 | Dec 2021 | $-0.13 | - | $-0.12 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 16, 2022 | Dec 2021 | $70.00K | - | $221.00K |
Entera Bio Ltd's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.13 | $-0.16 | $-0.10 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.84 | $-0.91 | $-0.78 |
| Dec 2022 | 2 | $-0.58 | $-0.61 | $-0.56 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.13 | $-0.13 | $-0.15 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.84 | $-0.84 | $-0.80 |
| Dec 2022 | 0 / 0 | $-0.58 | $-0.58 | $-0.56 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $70.00K | $0.00 | $130.00K |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $390.00K | $270.00K | $520.00K |
| Dec 2022 | 2 | $340.00K | $0.00 | $670.00K |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 17, 2021 | Sep 2021 | $-0.11 | - | - |
| Aug 16, 2021 | Jun 2021 | $-0.12 | $-0.21 | -75.00% |
| May 20, 2021 | Mar 2021 | $-0.12 | $-0.43 | -258.33% |
| Mar 18, 2021 | Dec 2020 | $-0.14 | $-0.12 | 14.29% |
| Nov 19, 2020 | Sep 2020 | $-0.20 | $-0.09 | 55.00% |
| Aug 20, 2020 | Jun 2020 | $-0.12 | $-0.17 | -41.67% |
| May 21, 2020 | Mar 2020 | - | $-0.16 | - |
| Mar 26, 2020 | Dec 2019 | $-0.19 | $-0.26 | -36.84% |
| Nov 21, 2019 | Sep 2019 | $-0.15 | $-0.25 | -66.67% |
| Aug 20, 2019 | Jun 2019 | $-0.28 | $-0.12 | 57.14% |
| Jun 27, 2019 | Mar 2019 | - | $-0.26 | - |
| Mar 28, 2019 | Dec 2018 | $-0.35 | $-0.17 | 51.43% |
| Sep 30, 2018 | Sep 2018 | $-0.28 | $-0.45 | -60.71% |
| Aug 20, 2018 | Jun 2018 | $-0.08 | $-0.93 | -1062.50% |
| Jun 29, 2018 | Mar 2018 | $-0.08 | $-13.97 | -17362.50% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 18, 2021 | Dec 2020 | $-0.56 | $-0.54 | - |
| Mar 26, 2020 | Dec 2019 | $0.00 | $-0.89 | - |
| Mar 28, 2019 | Dec 2018 | $-1.48 | $-15.52 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 17, 2021 | Sep 2021 | $60.00K | - | - |
| Aug 16, 2021 | Jun 2021 | $109.00K | $109.00K | 1.00% |
| May 20, 2021 | Mar 2021 | $90.00K | $157.00K | 1.74% |
| Mar 18, 2021 | Dec 2020 | $0.00 | $221.00K | - |
| Nov 19, 2020 | Sep 2020 | $0.00 | $50.00K | - |
| Aug 20, 2020 | Jun 2020 | - | $52.00K | - |
| May 21, 2020 | Mar 2020 | $42.00K | $42.00K | 1.00% |
| Mar 26, 2020 | Dec 2019 | $102.00K | $102.00K | 1.00% |
| Nov 21, 2019 | Sep 2019 | $0.00 | $60.00K | - |
| Aug 20, 2019 | Jun 2019 | $0.00 | $74.00K | - |
| Jun 27, 2019 | Mar 2019 | $0.00 | $500.00K | - |
| Mar 28, 2019 | Dec 2018 | $0.00 | $500.00K | - |
| Sep 30, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 20, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| Jun 29, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 18, 2021 | Dec 2020 | $140.00K | $365.00K | 160.71% |
| Mar 26, 2020 | Dec 2019 | $236.00K | $236.00K | 0.00% |
| Mar 28, 2019 | Dec 2018 | $0.00 | $500.00K | - |
ENTX's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Entera Bio Ltd's next quarterly earnings is $-0.13, with a low EPS estimation of $-0.16, and a high estimation of $-0.10.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.13, the last 2 month trend is $-0.13, and the 3 month trend is $-0.15.
Based on analysts, the average revenue estimation is $70.00K, with a low revenue estimation of $0.00, and a high estimation of $130.00K.
Entera Bio Ltd's previous earnings date was Nov 17, 2021 for its fiscal quarter ended Sep 30, 2021.
Entera Bio Ltd's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.
ENTX's earnings per share (EPS) was $-0.54, beating the consensus analysts forecast of $-0.56 by -3.27% , and higher than the previous year's EPS (Dec 2019) by -39.13%.
Revenues were $365.00K, better than the forecast of $140.00K by 160.71%, and up by 54.66% from previous year's revenue.
The company reported a net income of $-9.98M.
Entera Bio Ltd reported a free cash flow of $-10.48M for its fiscal year, compared to $-8.96M a year ago.
The company ended the fiscal year with $432.00K in total debt, an increase of 44.48% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
